Skip to main content

Table 1 Patient characteristics in the successful and failed conversion surgery groups

From: The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study

  SC group (n = 12) FC group (n = 38) P value
Gender (male) 11 (91.7%) 21 (55.3%) 0.02
Age 69.7 (±3.2) 68.6 (±1.8) 0.78
BMI 21.9 (±1.3) 20.9 (±0.7) 0.53
White blood cell (/μl) 6593 (±473) 6047 (±266) 0.32
NLR 2.4 (±0.6) 4.4 (±0.4) 0.008
Hemoglobin (g/dl) 11.2 (±0.4) 11.4 (±0.6) 0.79
Platelet count (× 104/μl) 31.3 (±3.6) 30.4 (±1.9) 0.81
CRP (mg/dl) 0.8 (±0.7) 1.3 (±0.4) 0.53
Total protein (g/dl) 6.8 (±0.2) 6.6 (±0.1) 0.38
Albumin (g/dl) 3.8 (±0.2) 3.4 (±0.1) 0.04
Cholinesterase (U/l) 230 (±27) 212 (±15) 0.55
CEA (<  5 ng/ml) 9 (75.0%) 20 (52.6%) 0.17
CA19–9 (<  37 U/ml) 10 (83.3%) 21 (55.3%) 0.08
CA125 (<  35 U/ml) 10 (83.3%) 34 (72.7%) 0.46
  1. Values are in n (%) or mean (± standard deviation)
  2. Abbreviations: BMI Body mass index, NLR neutrophil/lymphocyte ratio, CRP C-reactive protein, CEA carcinoembryonic antigen, CA 19–9 carbohydrate antigen 19–9, CA 125 carbohydrate antigen 125